Literature DB >> 23462292

Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23.

Fredrick R Schumacher1, Zhaoming Wang, Rolf I Skotheim, Roelof Koster, Charles C Chung, Michelle A T Hildebrandt, Christian P Kratz, Anne C Bakken, D Timothy Bishop, Michael B Cook, R Loren Erickson, Sophie D Fosså, Mark H Greene, Kevin B Jacobs, Peter A Kanetsky, Laurence N Kolonel, Jennifer T Loud, Larissa A Korde, Loic Le Marchand, Juan Pablo Lewinger, Ragnhild A Lothe, Malcolm C Pike, Nazneen Rahman, Mark V Rubertone, Stephen M Schwartz, Kimberly D Siegmund, Eila C Skinner, Clare Turnbull, David J Van Den Berg, Xifeng Wu, Meredith Yeager, Katherine L Nathanson, Stephen J Chanock, Victoria K Cortessis, Katherine A McGlynn.   

Abstract

Genome-wide association studies (GWASs) have identified multiple common genetic variants associated with an increased risk of testicular germ cell tumors (TGCTs). A previous GWAS reported a possible TGCT susceptibility locus on chromosome 1q23 in the UCK2 gene, but failed to reach genome-wide significance following replication. We interrogated this region by conducting a meta-analysis of two independent GWASs including a total of 940 TGCT cases and 1559 controls for 122 single-nucleotide polymorphisms (SNPs) on chromosome 1q23 and followed up the most significant SNPs in an additional 2202 TGCT cases and 2386 controls from four case-control studies. We observed genome-wide significant associations for several UCK2 markers, the most significant of which was for rs3790665 (PCombined = 6.0 × 10(-9)). Additional support is provided from an independent familial study of TGCT where a significant over-transmission for rs3790665 with TGCT risk was observed (PFBAT = 2.3 × 10(-3)). Here, we provide substantial evidence for the association between UCK2 genetic variation and TGCT risk.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23462292      PMCID: PMC3674801          DOI: 10.1093/hmg/ddt109

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  32 in total

1.  Gene variations in sex hormone pathways and the risk of testicular germ cell tumour: a case-parent triad study in a Norwegian-Swedish population.

Authors:  W Kristiansen; K E Andreassen; R Karlsson; E L Aschim; R M Bremnes; O Dahl; S D Fosså; O Klepp; C W Langberg; A Solberg; S Tretli; H-O Adami; F Wiklund; T Grotmol; T B Haugen
Journal:  Hum Reprod       Date:  2012-03-08       Impact factor: 6.918

Review 2.  A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer--experiences of the son.

Authors:  Michael B Cook; Olof Akre; David Forman; M Patricia Madigan; Lorenzo Richiardi; Katherine A McGlynn
Journal:  Int J Epidemiol       Date:  2010-07-26       Impact factor: 7.196

3.  Isolation of three testis-specific genes (TSA303, TSA806, TSA903) by a differential mRNA display method.

Authors:  K Ozaki; T Kuroki; S Hayashi; Y Nakamura
Journal:  Genomics       Date:  1996-09-01       Impact factor: 5.736

4.  Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism.

Authors:  Jacqueline R Starr; Chu Chen; David R Doody; Li Hsu; Sherianne Ricks; Noel S Weiss; Stephen M Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-09       Impact factor: 4.254

5.  Architecture of the human regulatory network derived from ENCODE data.

Authors:  Mark B Gerstein; Anshul Kundaje; Manoj Hariharan; Stephen G Landt; Koon-Kiu Yan; Chao Cheng; Xinmeng Jasmine Mu; Ekta Khurana; Joel Rozowsky; Roger Alexander; Renqiang Min; Pedro Alves; Alexej Abyzov; Nick Addleman; Nitin Bhardwaj; Alan P Boyle; Philip Cayting; Alexandra Charos; David Z Chen; Yong Cheng; Declan Clarke; Catharine Eastman; Ghia Euskirchen; Seth Frietze; Yao Fu; Jason Gertz; Fabian Grubert; Arif Harmanci; Preti Jain; Maya Kasowski; Phil Lacroute; Jing Jane Leng; Jin Lian; Hannah Monahan; Henriette O'Geen; Zhengqing Ouyang; E Christopher Partridge; Dorrelyn Patacsil; Florencia Pauli; Debasish Raha; Lucia Ramirez; Timothy E Reddy; Brian Reed; Minyi Shi; Teri Slifer; Jing Wang; Linfeng Wu; Xinqiong Yang; Kevin Y Yip; Gili Zilberman-Schapira; Serafim Batzoglou; Arend Sidow; Peggy J Farnham; Richard M Myers; Sherman M Weissman; Michael Snyder
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

6.  Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer.

Authors:  Clare Turnbull; Elizabeth A Rapley; Sheila Seal; David Pernet; Anthony Renwick; Deborah Hughes; Michelle Ricketts; Rachel Linger; Jeremie Nsengimana; Panagiotis Deloukas; Robert A Huddart; D Timothy Bishop; Douglas F Easton; Michael R Stratton; Nazneen Rahman
Journal:  Nat Genet       Date:  2010-06-13       Impact factor: 38.330

7.  A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression.

Authors:  Shunsuke Meike; Tohru Yamamori; Hironobu Yasui; Masato Eitaki; Akira Matsuda; Masami Morimatsu; Masakazu Fukushima; Yasundo Yamasaki; Osamu Inanami
Journal:  Mol Cancer       Date:  2011-07-28       Impact factor: 27.401

8.  Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis.

Authors:  D Forman; R T Oliver; A R Brett; S G Marsh; J H Moses; J G Bodmer; C E Chilvers; M C Pike
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

9.  Familial risk in testicular cancer as a clue to a heritable and environmental aetiology.

Authors:  K Hemminki; X Li
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

10.  Sensitivity of human cancer cells to the new anticancer ribo-nucleoside TAS-106 is correlated with expression of uridine-cytidine kinase 2.

Authors:  Yuji Shimamoto; Katsuhisa Koizumi; Hiroyuki Okabe; Hiromi Kazuno; Yuko Murakami; Fumio Nakagawa; Akira Matsuda; Takuma Sasaki; Masakazu Fukushima
Journal:  Jpn J Cancer Res       Date:  2002-07
View more
  38 in total

1.  Genetic and epigenetic analysis of monozygotic twins discordant for testicular cancer.

Authors:  Christian P Kratz; Daniel C Edelman; Yonghong Wang; Paul S Meltzer; Mark H Greene
Journal:  Int J Mol Epidemiol Genet       Date:  2014-10-22

2.  Future of testicular germ cell tumor incidence in the United States: Forecast through 2026.

Authors:  Armen A Ghazarian; Scott P Kelly; Sean F Altekruse; Philip S Rosenberg; Katherine A McGlynn
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

Review 3.  Molecular biology of testicular germ cell tumors.

Authors:  R Gonzalez-Exposito; M Merino; C Aguayo
Journal:  Clin Transl Oncol       Date:  2015-10-19       Impact factor: 3.405

Review 4.  Genetic changes associated with testicular cancer susceptibility.

Authors:  Louise C Pyle; Katherine L Nathanson
Journal:  Semin Oncol       Date:  2016-09-20       Impact factor: 4.929

5.  Increasing Incidence of Testicular Germ Cell Tumors among Racial/Ethnic Minorities in the United States.

Authors:  Armen A Ghazarian; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-08       Impact factor: 4.254

6.  Recent trends in the incidence of testicular germ cell tumors in the United States.

Authors:  A A Ghazarian; B Trabert; S S Devesa; K A McGlynn
Journal:  Andrology       Date:  2014-10-20       Impact factor: 3.842

Review 7.  Testicular cancer: biology and biomarkers.

Authors:  Leendert H J Looijenga; Hans Stoop; Katharina Biermann
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

8.  Variants in BAK1, SPRY4, and GAB2 are associated with pediatric germ cell tumors: A report from the children's oncology group.

Authors:  Erin L Marcotte; Nathan Pankratz; James F Amatruda; A Lindsay Frazier; Mark Krailo; Stella Davies; Jacqueline R Starr; Ching C Lau; Michelle Roesler; Erica Langer; Caroline Hallstrom; Anthony J Hooten; Jenny N Poynter
Journal:  Genes Chromosomes Cancer       Date:  2017-04-04       Impact factor: 5.006

Review 9.  [Genetics of testicular germ cell tumors].

Authors:  I Verdorfer
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

10.  Incidence of testicular germ cell tumors among US men by census region.

Authors:  Armen A Ghazarian; Britton Trabert; Barry I Graubard; Stephen M Schwartz; Sean F Altekruse; Katherine A McGlynn
Journal:  Cancer       Date:  2015-08-17       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.